InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Explore the complete record of transactions filed by Norden Gregory, Director. Officer active across 4 companies, notably NanoString Technologies Inc. Cumulatively, 13 reports have been logged. Total volume traded: €2m. The latest transaction was filed on 14 May 2026 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations13 total
€138,3843,045 shares@ €45.44640.0005% mcap100.0% of flow
Class A Ordinary Shares
SEC:0001405104-26-000002·
€138,3843,045 shares@ €45.44640.0005% mcap50.0% of flow
Class A Ordinary Shares
SEC:0001405104-26-000002:0·
06,328 shares0
Class A Ordinary Shares
SEC:0000899243-22-024045:0·
03,890 shares0
Common Stock
SEC:0001401708-22-000124:0·
2,673 shares
Common Stock
SEC:0001555280-22-000103:0·
€841,4414,500 shares@ €186.9870.0027% mcap100.0% of flow
Common Stock
SEC:0001555280-21-000336·
€841,4414,500 shares@ €186.9870.0027% mcap50.0% of flow
Common Stock
SEC:0001555280-21-000336:0·
02,826 shares0
Common Stock
SEC:0001689548-21-000068·
02,826 shares0
Common Stock
SEC:0001689548-21-000068:0·
05,726 shares0
Class A Ordinary Shares
SEC:0000950103-21-009688·
05,726 shares0
Class A Ordinary Shares
SEC:0000950103-21-009688:0·
5,520 shares
Common Stock
SEC:0001401708-21-000178·
5,520 shares
Common Stock
SEC:0001401708-21-000178:0·
13 of 13 declarations
About Norden Gregory
Gregory Norden is a Board Member at NanoString Technologies Inc, Royalty Pharma plc, and Praxis Precision Medicines, Inc. In these roles, he contributes to the governance of the companies and strategic decision-making. His experience in the biopharmaceutical sector allows him to bring valuable insights to help guide development and innovation strategies.
